Refine
Year of publication
- 2023 (1)
Document Type
- Article (1)
Language
- English (1)
Has Fulltext
- yes (1)
Publication reviewed
- begutachtet (1)
Keywords
- Antikoagulation (1)
- Frailty (1)
- anticoagulation (1)
- frailty (1)
Institute
Background: Frailty makes older adults vulnerable to adverse health outcomes and can modify pharmacokinetics and drug
exposure.
Objective: We aimed to explore the relationship between different frailty assessments and trough plasma concentrations of direct oral anticoagulants in older patients.
Methods: The frailty status of adults aged ≥ 70 years receiving regular direct oral anticoagulant medication was assessed
by four different instruments: Fried physical phenotype, Rockwood frailty index, Short Physical Performance Battery, and FRAIL scale. The two performance measures “slow gait speed” and “weak grip strength” were used to build a separate score depending on the number of positive criteria (none, one, two). For each participant, a single steady-state direct oral anticoagulant trough plasma concentration was collected, dose-normalized, and its relationship to the various frailty assessments analyzed.
Results: Forty-two participants completed the study, with most using apixaban (n = 22). Dose-normalized apixaban trough
concentrations were 2.48-fold higher in frail participants (Fried phenotype) than in robust participants (p = 0.009) and correlated positively with Fried physical phenotype (rs = 0.535, p = 0.010) and negatively with Short Physical Performance
Battery (rs = − 0.434, p = 0.044). Compared with participants who met none of the criteria “slow gait speed” and “weak
grip strength”, apixaban trough concentrations were approximately 1.9-fold higher in participants who were positive for one (p = 0.018) or two (p = 0.013) of these measures.
Conclusions: In this exploratory study, higher levels of frailty on performance-based frailty assessments were associated
with higher apixaban exposure in older adults.